EU - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights

EU: Vaccine Market Overview 2019

Vaccine Market Size in the EU

The revenue of the vaccine market in the European Union amounted to $X in 2018, surging by X% against the previous year. Overall, vaccine consumption continues to indicate a measured expansion. The most prominent rate of growth was recorded in 2018 when the market value increased by X% against the previous year. In that year, the vaccine market attained its peak level and is likely to continue its growth in the immediate term.

Vaccine Production in the EU

In value terms, vaccine production totaled $X in 2018 estimated in export prices. The total output indicated strong growth from 2007 to 2018: its value increased at an average annual rate of +X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2018 figures, vaccine production increased by +X% against 2014 indices. The pace of growth was the most pronounced in 2014 when production volume increased by X% year-to-year. The level of vaccine production peaked in 2018 and is likely to see steady growth in the immediate term.

Production By Country in the EU

Ireland (X tonnes) constituted the country with the largest volume of vaccine production, accounting for X% of total production. Moreover, vaccine production in Ireland exceeded the figures recorded by the region's second-largest producer, France (X tonnes), twofold. The third position in this ranking was occupied by Germany (X tonnes), with a X% share.

From 2007 to 2018, the average annual growth rate of volume in Ireland stood at +X%. In the other countries, the average annual rates were as follows: France (+X% per year) and Germany (+X% per year).

Vaccine Exports

Exports in the EU

In 2018, approx. X tonnes of vaccines for human medicine were exported in the European Union; growing by X% against the previous year. The total exports indicated a remarkable expansion from 2007 to 2018: its volume increased at an average annual rate of +X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2018 figures, vaccine exports increased by +X% against 2016 indices. The growth pace was the most rapid in 2018 when exports increased by X% y-o-y. In that year, vaccine exports reached their peak and are likely to continue its growth in the immediate term.

In value terms, vaccine exports totaled $X in 2018. The total exports indicated a resilient expansion from 2007 to 2018: its value increased at an average annual rate of +X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2018 figures, vaccine exports increased by +X% against 2016 indices. The most prominent rate of growth was recorded in 2009 with an increase of X% year-to-year. Over the period under review, vaccine exports reached their peak figure in 2018 and are expected to retain its growth in the near future.

Exports by Country

Ireland (X tonnes) and Belgium (X tonnes) represented the key exporters of vaccines for human medicine in 2018, resulting at approx. X% and X% of total exports, respectively. France (X tonnes) ranks next in terms of the total exports with a X% share, followed by Italy (X%) and the UK (X%). The following exporters - Poland (X tonnes), the Netherlands (X tonnes) and Denmark (X tonnes) - together made up X% of total exports.

From 2007 to 2018, the most notable rate of growth in terms of exports, amongst the main exporting countries, was attained by Poland (+X% per year), while the other leaders experienced more modest paces of growth.

In value terms, Ireland ($X), Belgium ($X) and France ($X) were the countries with the highest levels of exports in 2018, together comprising X% of total exports. These countries were followed by Italy, the Netherlands, the UK, Poland and Denmark, which together accounted for a further X terms of the main exporting countries, Poland recorded the highest growth rate of exports, over the last eleven-year period, while the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2018, the vaccine export price in the European Union amounted to $X per kg, reducing by -X% against the previous year. Overall, the vaccine export price, however, continues to indicate a relatively flat trend pattern. The growth pace was the most rapid in 2011 when the export price increased by X% y-o-y. The level of export price peaked at $X per kg in 2017, and then declined slightly in the following year.

Prices varied noticeably by the country of origin; the country with the highest price was France ($X per kg), while Denmark ($X per kg) was amongst the lowest.

From 2007 to 2018, the most notable rate of growth in terms of prices was attained by the Netherlands, while the other leaders experienced more modest paces of growth.

Vaccine Imports

Imports in the EU

The imports totaled X tonnes in 2018, increasing by X% against the previous year. Over the period under review, vaccine imports continue to indicate a prominent expansion. The most prominent rate of growth was recorded in 2018 with an increase of X% against the previous year. In that year, vaccine imports reached their peak and are likely to continue its growth in the immediate term.

In value terms, vaccine imports stood at $X in 2018. Over the period under review, vaccine imports continue to indicate buoyant growth. The growth pace was the most rapid in 2009 with an increase of X% against the previous year. Over the period under review, vaccine imports reached their maximum at $X in 2014; however, from 2015 to 2018, imports stood at a somewhat lower figure.

Imports by Country

Belgium prevails in vaccine imports structure, resulting at X tonnes, which was near X% of total imports in 2018. It was distantly followed by Poland (X tonnes), creating a X% share of total imports. Germany (X tonnes), Spain (X tonnes), France (X tonnes), the UK (X tonnes) and Italy (X tonnes) occupied a relatively small share of total imports.

Belgium was also the fastest-growing in terms of the vaccines for human medicine imports, with a CAGR of +X% from 2007 to 2018. At the same time, Poland (+X%), Spain (+X%), Italy (+X%) and France (+X%) displayed positive paces of growth. By contrast, Germany (-X%) and the UK (-X%) illustrated a downward trend over the same period. While the share of Belgium (+X p.p.) and Poland (+X p.p.) increased significantly in terms of the total imports from 2007-2018, the share of the UK (-X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Belgium ($X) constitutes the largest market for imported vaccines for human medicine in the European Union, comprising X% of total vaccine imports. The second position in the ranking was occupied by the UK ($X), with a X% share of total imports. It was followed by Germany, with a X% share.

In Belgium, vaccine imports expanded at an average annual rate of +X% over the period from 2007-2018. In the other countries, the average annual rates were as follows: the UK (+X% per year) and Germany (+X% per year).

Import Prices by Country

In 2018, the vaccine import price in the European Union amounted to $X per kg, shrinking by -X% against the previous year. Overall, the vaccine import price, however, continues to indicate a remarkable expansion. The pace of growth appeared the most rapid in 2009 when the import price increased by X% against the previous year. The level of import price peaked at $X per kg in 2017, and then declined slightly in the following year.

Prices varied noticeably by the country of destination; the country with the highest price was the UK ($X per kg), while Belgium ($X per kg) was amongst the lowest.

From 2007 to 2018, the most notable rate of growth in terms of prices was attained by the UK, while the other leaders experienced more modest paces of growth.

Source: IndexBox AI Platform